Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
12.39
-0.13 (-1.04%)
Dec 20, 2024, 4:00 PM EST - Market closed
Greenwich LifeSciences Market Cap
Greenwich LifeSciences has a market cap or net worth of $162.86 million as of December 20, 2024. Its market cap has increased by 4.33% in one year.
Market Cap
162.86M
Enterprise Value
157.04M
1-Year Change
4.33%
Ranking
Category
Stock Price
$12.39
Market Cap Chart
Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $162.86M, an increase of 137.10%. That is a compound annual growth rate of 22.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 162.86M | 20.49% |
| Dec 29, 2023 | 135.16M | -30.79% |
| Dec 30, 2022 | 195.29M | -38.84% |
| Dec 31, 2021 | 319.29M | -31.08% |
| Dec 31, 2020 | 463.30M | 574.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elutia | 167.28M |
| Nkarta | 167.25M |
| Solid Biosciences | 166.21M |
| Fennec Pharmaceuticals | 164.29M |
| Caribou Biosciences | 162.99M |
| Innate Pharma | 162.24M |
| 2seventy bio | 161.99M |
| EUDA Health Holdings | 160.88M |